Mobile-Menu

Johnson & Johnson, Novartis, et al Top 10 Pharmaceutical Companies by Revenue

Editor: Dipl.-Medienwirt (FH) Matthias Back |

An unprecedented acquisition battle is currently being waged in the pharmaceutical industry. Pfizer has launched an 85.2 million euro bid for Astra Zeneca, and Valeant has upped its takeover offer for Botox maker Allergan to $47 billion. Bayer has gone even further and has reported the $14.2 billion takeover of Merck’s over-the-counter drugs business. The time has come for PROCESS to take a closer look.

Related Vendors

Hans Turck GmbH & Co. KG
Glatt Ingenieurtechnik GmbH
Maag Pump Systems AG
Johnson & Johnson had a workforce of around 128,000 in 60 countries worldwide. The company had 800 employees in Germany at sites in Neuss (330) and Wuppertal and at regional offices. Corporate headquarters in New Brunswick NJ, USA is shown in the photo.
Johnson & Johnson had a workforce of around 128,000 in 60 countries worldwide. The company had 800 employees in Germany at sites in Neuss (330) and Wuppertal and at regional offices. Corporate headquarters in New Brunswick NJ, USA is shown in the photo.
(Picture: Johson & Johnson)

Würzburg. With sales of US $ 71.31 billion dollars, US pharmaceutical and consumer goods producer Johnson & Johnson was the world’s top-ranking pharmaceutical company by revenue in 2013. The Swiss companies Novartis (US $ 57.9 billion) and Roche (US $ 52.58 billion) were ranked second and third respectively. The figure for Roche is based revenues of 46.8 billion CHF as reported in the financial statement at an exchange rate of 1.1234 on 31 December 2013. The rankings are based on total corporate sales for the full year. The position in the rankings can vary depending on the frame of reference and the financial statements which are included or excluded in the analysis.

(See our photo gallery of the Top Ten pharmaceutical companies by revenue to learn more about the companies.)

Gallery
Gallery with 35 images

With sales of US $ 51.6 billion, the American company Pfizer was 4th in the worldwide revenue rankings. If the company’s British competitor Astra Zeneca accepts the takeover bid, Pfizer would immediately become the undisputed number one in the industry. However last week, Astra Zeneca rejected the latest 85.2 billion euro offer.

Sanofi, GSK and Merck Head-to-Head in Big–Pharma–Top–Ten

The field is more tightly packed in places 5 - 7. The spread is a mere US $ 2 billion. The French company Sanofi with sales of US $ 45.37 billion (revenue of 32.9 billion euros reported in the financial statement, exchange rate 1.3791 as of 31 December 2013) is ranked 5th, just ahead of British producer Glaxo Smith Kline at US $ 45.32 billion (revenue of GBP 27.4 billion reported in the financial statement, exchange rate 1.6542 as of 31 December 2013) and the American corporation Merck at US $ 44 billion.

Continue reading the next page to find out which companies are ranked 8th – 10th and which have the largest workforces.

(ID:42720061)

Related content